Erik Lundgren
CIK: 0002137540
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMUX
IMMUNIC, INC.
Officer
Discretionary Trading P&L
Holdings
About Lundgren Erik
Lundgren Erik (SEC CIK 0002137540) files insider reports with the SEC as Chief Executive Officer of IMMUNIC, INC. (IMUX).
Signal8 holds 2 ownership filings by Lundgren Erik (1 Form 3, 1 Form 4), filed on Jun 1, 2026. Those filings report 1 transaction, the latest on May 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lundgren Erik's filings is in NEW YORK, NY.
Recent filings by Lundgren Erik
- May 22, 2026: Grant or award of IMUX derivative securities (Form 4, code A).
Other insiders filing for IMMUNIC, INC. (IMUX)
- Nagel Robert Thorvald, Director
- BVF PARTNERS L P/IL, Director
- Ridloff Elena, Director
- Skerjanec Simona, Director
- Rudick Richard Alan, Director
- PHILLIPS BARCLAY A, Director